SNRPD1 and breast cancer: Through computational predictions followed by experimental validations, we proposed in this study that SNRPD1 over-expression contributes to cell cycle progression whose differential expression is prognostic of breast cancer outcome and associated with breast cancer subtypes, and targeting SNRPD1 could lead to cell cycle arrest at the G0/G1 stage.